No 10Y consistency score yet for revenue — the window needs more comparable quarters.
Valuation vs own 10Y history: P/S N/A · No P/S — trailing revenue unavailable or non-positive.
Chart series for revenue are being prepared.
No 10Y consistency score yet for revenue — the window needs more comparable quarters.
Valuation vs own 10Y history: P/S N/A · No P/S — trailing revenue unavailable or non-positive.
Chart series for revenue are being prepared.
The latest delayed quote for Eocene Ltd. (EOCN) stock was $3.32 as of Oct 6, 2026, 12:22 PM EDT, down 3.77% from the previous close.
Eocene Ltd. is a clinical-stage drug development biopharmaceutical company, which engages in the development of oral therapy for the treatment of non-alcoholic steato-hepatitis (NASH).
Medical - Pharmaceuticals · Ramat Gan, TA
LATEST PRICE
$3.32
52-WEEK RANGE
$3.12 - $13.20
BETA
0.66
% FROM 52W HIGH
-74.85%
MARKET CAP
$3.46M
DIVIDEND YIELD
Never paid
N/A
PE RATIO
trailing TTM
N/A
PE RATIO (FWD)
forward FY estimate
N/A
P/B RATIO
N/A
P/S RATIO
TTM
N/A
P/OCF RATIO
TTM
N/A
EV/EBITDA
TTM
N/A
DEBT / EQUITY
N/A
REVENUE TTM
N/A
GROSS MARGIN TTM
N/A
NET PROFIT MARGIN TTM
N/A
REVENUE GROWTH TTM
TTM vs prior TTM
N/A
REVENUE CAGR 3Y
N/A
REVENUE CAGR 5Y
N/A
TTM TOTAL RETURN
N/A
3Y TOTAL RETURN
annualized (CAGR)
N/A
5Y TOTAL RETURN
annualized (CAGR)
N/A
Next Earnings Date
N/A
EPS Estimate
N/A
Revenue Est.
N/A
Last Quarter Results
EPS
$-2.86
vs Estimate
$-3.12
Revenue
N/A
vs Estimate
N/A
Consensus Rating
Average Price Target
N/A
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR | Compare |
|---|---|---|---|---|---|---|---|
| 1EOCN | $3.46M | $3.32 | -3.77% | N/A | N/A | N/A | N/A |
| 2MLEC | $3.46M | $4.77 | -1.85% | -64.99% | -68.13% | N/A | vs EOCN |
| 3CVKD | $3.42M | $0.96 | +1.50% | -93.24% | N/A | N/A | vs EOCN |
| 4MBIO | $3.49M | $0.46 | +0.20% | -70.71% | -80.80% | N/A | vs EOCN |
| 5NXL | $3.51M | $4.79 | -11.79% | -79.96% | N/A | N/A | vs EOCN |
| 6EVGN | $3.55M | $0.41 | +1.96% | -64.71% | -56.46% | -39.70% | vs EOCN |
Low
N/A
Current
$3.32
High
N/A